Vaccine Trials Ongoing in Locally Advanced Oligometastatic Prostate Cancer
CancerNetwork® spoke with Ketan K. Badani, MD, vice chairman of Urology and Robotics and director of the Comprehensive Kidney Cancer Center and Reconstructive Urology at Mount Sinai Health System, about the phase 1 poly-ICLC trial (NCT03262103), which …